Etienne Raemy

Etienne Raemy is an experienced professional in the field of pharmacovigilance and drug safety, currently serving as the Head of Pharmacovigilance at Debiopharm since December 2022. Prior to this role, Etienne worked at Incyte from June 2019 to November 2022, initially as a Drug Safety Associate and later as a Specialist in Pharmacovigilance Affiliate Governance and QPPV Office. Previous experience includes positions as a Safety Scientist and Safety Data Associate at UBC between April 2017 and May 2019, and as a Scientific Associate in Technology Transfer at the University of Geneva from December 2015 to October 2016, where responsibilities included evaluating patentability and negotiating agreements. Etienne's academic background includes a PhD in Biology, an MSc in Biology, and a BSc in Biology, all obtained from the University of Geneva between 2005 and 2015.